The participation of matrix metalloproteinases-9 and TIMP-1 in formation of atrial fibrillation paroxisms in patients with metabolic syndrome

Authors

  • V.A. Akhmedov Omsk state medical academy, 12, Lenina str., Omsk, 644043, Russia
  • V.T. Dolgikh Omsk state medical academy, 12, Lenina str., Omsk, 644043, Russia
  • D.V. Naumov Clinical Hospital of Omsk Passazhirsky station, 41, Karbyshev str., Omsk, 644099, Russia
  • N.A. Nechiporenko Clinical Hospital of Omsk Passazhirsky station, 41, Karbyshev str., Omsk, 644099, Russia

Keywords:

MMP-9, TIMP-1, atrial fibrillation, metabolic syndrome, gene polymorphism

Abstract

The aim of this study was to estimate the role of matrix metalloproteinases activity (MMP-9, TIMP-1) and gene polymorphism at the patients with metabolic syndrome in combination with paroxysmal form of atrial fibrillation. The 60 patients with metabolic syndrome in combination with paroxysmal form of atrial fibrillation were investigated with estimation of serum levels of MMP-9, TIMP-1 and mutation of genes of angiotenzinogen 1 Thr 174 Met, angiotenzinogen 2 Met 235 Thr and apolipoprorein C3 C3238 G. In patients with metabolic syndrome in combination with paroxysmal form of atrial fibrillation the significant increase synthesis of MMP-9 level can lead to increase of atrial fibrillation paroxysms because of increase synthesis of collagen tissue in myocard and vessel walls. Also the significant high incidence of angiotenzinogen 2 Met 235 Thr mutation was established.

Downloads

Published

2013-11-29

Issue

Vol. 57 No. 4 (2013)

Section

Original research

How to Cite

[1]
2013. The participation of matrix metalloproteinases-9 and TIMP-1 in formation of atrial fibrillation paroxisms in patients with metabolic syndrome. Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya (Pathological physiology and experimental therapy). 57, 4 (Nov. 2013), 46–50.